By synergizing GSMR, MVMR, IVW-MR and SMR with multi-omics integration, this work not only establishes Cathepsin H as a novel therapeutic target for PDR and diabetic maculopathy but also pioneers a translational paradigm bridging genetic association to clinical intervention. The gene discussed is CTSH; the disease is diabetic maculopathy.